House leaders and White House negotiators are unable to break the impasse created by conservatives, who say the bill does not sufficiently unravel Obamacare, and moderates who worry about lack of coverage for constituents.
Editor's note: There have been multiple updates to this story. Please see the following articles: Ryan Tells Trump: Votes Not There for AHCA and House GOP Pulls ACA Replacement Bill.
The Associated Press is reporting that House Republican leaders will delay today’s scheduled vote on the American Health Care Act (AHCA), with House Speaker Paul Ryan and White House negotiators unable to get enough votes for the bill.
Leaders have been trying for days to get the needed votes for the bill to replace the Affordable Care Act (ACA) to clear the House. But they were apparently unable to crack the logjam created by conservatives who feel the current version of the AHCA does not go far enough to remove the ACA’s regulations and moderates who fear too many of their constituents will lose their coverage.
Earlier this afternoon, White House Press Secretary Sean Spicer insisted, “It’s going to pass. So that’s it,” when asked about the AHCA’s prospects.
But late efforts to strip out the essential health benefits, a core provision of the ACA that require mental health coverage and have shifted the focus toward preventive care, were not enough to convince conservatives in the Freedom Caucus to get on board.
Also, the Congressional Budget Office today released an updated score of the revised AHCA. While the number of people projected to lose coverage through 2026 remained unchanged at 24 million, the deficit reduction estimate was cut in half, from $337 billion to $150 billion over 10 years.
(See earlier coverage on the role of essential health benefits in negotiations.)
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More